- Home
- POLA vs INM Comparison
POLA vs INM Comparison
Compare POLA & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POLA
- INM
- Stock Information
- Founded
- POLA 1979
- INM 1981
- Country
- POLA United States
- INM Canada
- Employees
- POLA N/A
- INM N/A
- Industry
- POLA Industrial Machinery/Components
- INM Biotechnology: Pharmaceutical Preparations
- Sector
- POLA Miscellaneous
- INM Health Care
- Exchange
- POLA Nasdaq
- INM Nasdaq
- Market Cap
- POLA 5.2M
- INM 4.3M
- IPO Year
- POLA 2016
- INM N/A
- Fundamental
- Price
- POLA $2.69
- INM $2.36
- Analyst Decision
- POLA
- INM
- Analyst Count
- POLA 0
- INM 0
- Target Price
- POLA N/A
- INM N/A
- AVG Volume (30 Days)
- POLA 909.7K
- INM 55.0K
- Earning Date
- POLA 11-13-2025
- INM 11-13-2025
- Dividend Yield
- POLA N/A
- INM N/A
- EPS Growth
- POLA N/A
- INM N/A
- EPS
- POLA N/A
- INM N/A
- Revenue
- POLA $11,967,000.00
- INM $4,920,990.00
- Revenue This Year
- POLA N/A
- INM N/A
- Revenue Next Year
- POLA N/A
- INM N/A
- P/E Ratio
- POLA N/A
- INM N/A
- Revenue Growth
- POLA 0.14
- INM N/A
- 52 Week Low
- POLA $1.53
- INM $1.72
- 52 Week High
- POLA $4.69
- INM $8.27
- Technical
- Relative Strength Index (RSI)
- POLA 62.21
- INM 56.86
- Support Level
- POLA $2.26
- INM $2.11
- Resistance Level
- POLA $3.67
- INM $2.45
- Average True Range (ATR)
- POLA 0.34
- INM 0.11
- MACD
- POLA 0.02
- INM 0.04
- Stochastic Oscillator
- POLA 39.88
- INM 78.57
About POLA Polar Power Inc.
Polar Power Inc is engaged in designing, manufacturing, and selling DC power generators, renewable energy, and cooling systems for applications in the telecommunications market and, to a lesser extent, in other markets, including military, electric vehicle, marine, and industrial. The company's products include DC generators, backup DC generators, hybrid power systems, Li-Ion battery systems, Marine DC generators, and others. The company's geographical presence is in the United States, Canada, Australia and South Pacific Islands, Asia, Europe and Middle East, United Kingdom, Other North America, South Africa, and others.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.